Elan

Elan Revives Plan to Spin Off Its Drug Delivery Unit
Bloomberg
Mon, 04/19/10 - 11:14 am
Elan
drug delivery
Biogen Idec and Elan plan Tysabri-comparison study
Marketwatch
Thu, 03/25/10 - 09:38 am
Elan
Biogen Idec
Tysabri
Rebif
Copaxone
Merck Serono
Teva Pharmaceuticals
Biogen: Now 42 Cases Of Brain Infection In Tysabri Patients
WSJ Online
Thu, 03/18/10 - 07:28 am
Biogen Idec
Elan
Tysabri
MS
PML
Warning: Not All Boxed Warnings Are Equal
Motley Fool
Mon, 03/15/10 - 04:21 pm
black box
warnings
Plavix
Bristol-Myers Squibb
Biogen Idec
Elan
Tysabri
Sanofi
Elan Sticks It To Shareholders With J&J Deal
Pharmalot
Mon, 03/15/10 - 12:03 pm
JNJ
Elan
Alzheimer's disease
Elan execs get $8M in stock awards
Fierce Pharma
Mon, 03/1/10 - 11:49 am
Elan
Stronger Label for Biogen's Tysabri
Yahoo/Zacks.com
Mon, 03/1/10 - 10:00 am
Biogen Idec
Elan
Tysabri
multiple sclerosis
Elan expects rare operating profit in 2010
Reuters
Wed, 02/10/10 - 09:00 am
Elan
earnings
guidance
FDA orders stronger label for Tysabri
bizjournals.com
Sat, 02/6/10 - 12:00 pm
Tysabri
Biogen Idec
PML
Elan
2010: A Big Year for Big Pharma
Seeking Alpha
Mon, 01/25/10 - 12:41 pm
Big Pharma
Pfizer
Bristol-Myers Squibb
Vertex Pharmaceuticals
Merck
Elan
Matthew Herper And Robert Langreth On The Pharmaceutical Industry: in 2010, a major drug company will break up
Forbes
Mon, 12/28/09 - 05:01 am
JNJ
Medtronic
Pfizer
Vytorin
Boehringer Ingelheim
Elan
Eli Lilly
Fate Therapeutics
Gilead Sciences
Merck
Schering Plough
Wyeth
The 5 Worst Drug Companies of 2009
BNET Pharma
Mon, 12/28/09 - 04:40 am
Mylan
Elan
Genzyme
Sequenom
Ranbaxy
Five Biotech Events to Watch in 2010
TheStreet.com
Wed, 12/16/09 - 11:22 am
biotech
Medivation
Elan
Pfizer
Dendreon
Vertex Pharmaceuticals
Amgen
InterMune
Elan, Transition modify Alzheimer drug trial
Marketwatch
Tue, 12/15/09 - 09:24 am
Alzheimer's disease
Elan
Transition Therapeutics
Elan: J&J unit seeks Europe schizophrenia-drug OK
Marketwatch
Mon, 12/7/09 - 12:20 pm
Europe
schizophrenia
Elan
JNJ
When Rival Drug Makers Compare Notes On Safety Problems
WSJ Online
Wed, 11/11/09 - 05:57 pm
Elan
Biogen Idec
Roche
Tysabri
drug safety
Elan, Biogen change Tysabri label due to PML risk
Reuters
Mon, 11/9/09 - 10:07 am
Elan
Biogen Idec
Tysabri
PML
MS
J&J's New Acquisition Strategy Makes Sense
Seeking Alpha
Fri, 10/30/09 - 06:50 am
JNJ
M&A
Elan
Crucell
More PML Troubles for Biogen, Elan MS Drug
TheStreet.com
Thu, 10/29/09 - 10:28 am
Biogen Idec
Elan
PML
Tysabri
MS
multiple sclerosis
Reviving Tysabri
Forbes
Tue, 10/27/09 - 04:32 pm
Tysabri
Elan
Biogen Idec
MS
multiple sclerosis

Pages